Apixaban and Alcohol: What the Guidance Says, and What It Leaves Out

The NHS medicines page for apixaban says you can eat and drink as normal. That is the only thing it says about alcohol. It is also not the whole picture, because NICE separately tells clinicians to treat harmful drinking as a bleeding risk factor to be actively managed in people on anticoagulants.

Both of those are true at once. This page explains the gap, because the reader who needs it most is the one the NHS page does not address.

If you are bleeding, deal with that first

Apixaban makes bleeding more likely and harder to stop. The NHS apixaban page lists heavy or internal bleeding as a more common serious side effect, and names what to look for: blood in your urine or stools, blood in your vomit or coughing up blood, bleeding in the brain, and bleeding from a surgical wound. For bleeding in the brain it describes a sudden bad headache with confusion, sensitivity to light, slurred speech, difficulty moving your arms or legs, or feeling or being sick.

The NHS also says to call 111 if you are taking apixaban and you have symptoms of bleeding, if you have had a head injury, or if you think you might be having other serious side effects. Separately, its alcohol-related liver disease page treats vomiting blood, or stools that are black and look sticky, as a 999 call.

If you are outside the UK, use your local emergency number. If you have been drinking and you are not sure whether what you are feeling is the drink or a bleed, that uncertainty is itself a reason to get seen. Intoxication hides the symptoms of a brain bleed rather well.

You should also have been given an anticoagulant alert card. Carry it.

The sources say different things, and both are official

The NHS medicines page gives no drinking limit, no binge warning and no caution at all. The word alcohol appears once on it, as a heading.

NICE guidance on atrial fibrillation reads differently. It tells clinicians to offer monitoring and support to modify risk factors for bleeding, and lists harmful alcohol consumption among them alongside uncontrolled hypertension and concurrent NSAIDs, SSRIs and antiplatelets. NICE guidance on venous thromboembolism says people on anticoagulation should be given information about how other medications, foods and alcohol can affect treatment.

The NHS page for atrial fibrillation, the commonest reason to be on apixaban, tells people not to drink too much.

So the patient-facing medicines page is silent while the clinical guidance is not. We are not going to resolve that for you. We think the honest reading is that “eat and drink as normal” is written for someone drinking within the ordinary population guidance, and that it was never meant to answer the question a heavy drinker is asking.

Alcohol is not a listed interaction. That is not the same as safe.

We checked this properly. Alcohol appears nowhere in the UK Summary of Product Characteristics for apixaban, and nowhere in the US prescribing information either. Two regulators, no mention.

Read that precisely. Alcohol is not a known pharmacokinetic interaction, in the way certain antifungals and rifampicin are. That does not make drinking harmless on an anticoagulant, because the risk here does not run through the drug at all. It runs through bleeding risk, the gut, the liver, falls and missed doses, and every one of those is real.

Where the risk actually sits

Your gut. The apixaban label treats current or recent gastrointestinal ulceration as a significant risk factor for major bleeding, serious enough to sit among the contraindications, along with known or suspected oesophageal varices. Heavy sustained drinking is a route to both.

Alcohol also raises upper gastrointestinal bleeding risk on its own, steeply at the top end. A large case-control study found the relative risk of major upper GI bleeding rising across drinking categories to more than sixfold in the heaviest band. A Danish cohort found the heaviest drinkers had roughly four times the risk of a bleeding ulcer. Neither study was done in anticoagulated people, and their drinking categories are not safe limits.

Painkillers. This is the most practical point on the page. The apixaban label warns that care is needed with NSAIDs, including aspirin, and with SSRIs and SNRIs, because they increase bleeding risk. It quantifies aspirin as raising major bleeding on apixaban from 1.8% per year to 3.4%. A prospective cohort separately found alcohol combined with NSAIDs or aspirin associated with a 75% higher risk of major gastrointestinal bleeding. Reaching for ibuprofen for a hangover, while on apixaban, stacks three things that push the same way.

What the evidence does and does not show, including the half that is inconvenient for us. A study of warfarin patients found alcohol misuse and heavy episodic drinking associated with roughly doubled odds of major bleeding (Roth et al, odds ratios of 2.10 and 2.36). That was warfarin, in one US health system, using self-reported drinking, with confidence intervals whose lower bounds sit close to no effect.

Pointing the other way, a prospective cohort of 3,852 people with atrial fibrillation, 84% of them on oral anticoagulants, found no significant association between alcohol consumption and bleeding, and its authors wrote that their findings do not support special recommendations on alcohol for people with established atrial fibrillation. Its heaviest drinking category was two or more drinks a day, so it contains few very heavy drinkers, and bleeding was a secondary outcome.

We could find no study of alcohol and major bleeding specifically in people taking apixaban or another DOAC. That gap is worth stating rather than papering over.

Alcohol is also not a component of ORBIT, the bleeding risk score NICE recommends for atrial fibrillation. It is a component of HAS-BLED, which NICE recommends for unprovoked venous thromboembolism. Which score your clinician uses depends on why you are anticoagulated.

Falls, and why a head injury is different for you

Falls are where anticoagulation and alcohol meet most dangerously, and the guidance here is specific.

UK head injury guidance says that for someone who has had a head injury and has no other reason for a scan, being on an anticoagulant is itself a reason to consider a CT head scan. The same guidance names current drug or alcohol intoxication as a separate trigger for referral to emergency care. Someone who is drunk and on apixaban has two independent triggers in the same list.

NICE’s 2025 falls guidance names alcohol misuse among the risk factors to identify in a falls assessment, which its 2013 predecessor did not mention at all. The World Health Organization also lists alcohol or substance use among falls risk factors.

The evidence is messier than that sounds, and we would rather show you than tidy it. One large cohort reported a 25% higher fall risk in its heaviest drinking group longitudinally, while the same paper’s cross-sectional analysis had the heaviest drinkers falling less, which the authors attributed to people at risk having already cut down. Neither trend reached significance. On whether a fall then bleeds more, a study of 77,834 older people attending emergency departments after head injury found higher intracranial haemorrhage risk with warfarin than with a DOAC, and no observed difference between DOAC users and people on no anticoagulant. That is reassuring only as far as people who already reached hospital.

One thing NICE is completely clear about, and it points the opposite way to the direction people assume: do not withhold anticoagulation solely because of someone’s age or their risk of falls. The answer to falling is not to stop the medicine.

The liver, where the link is tightest

This is where alcohol and apixaban connect most directly, and it gets the least coverage.

Hepatic disease associated with coagulopathy and clinically relevant bleeding risk is a contraindication to apixaban, as is known or suspected oesophageal varices. Both are conditions sustained heavy drinking causes. The label also says apixaban is not recommended in severe hepatic impairment, should be used with caution in mild or moderate impairment, and that liver function testing should be done before starting it.

If your drinking has already affected your liver, that is not a lifestyle footnote. It sits inside the contraindication list for the medicine you are taking.

Alcohol and atrial fibrillation itself

If you are on apixaban for atrial fibrillation, there is a finding here that is useful rather than merely cautionary.

A randomised trial in the New England Journal of Medicine took 140 regular drinkers with atrial fibrillation and randomised them to abstinence or usual drinking. Atrial fibrillation recurred in 53% of the abstinence group against 73% of controls, and time spent in atrial fibrillation was lower.

Two honest caveats. The control group also cut their drinking by about a fifth, so this was not abstinence versus unchanged drinking. And the trial was small, open-label, 85% men, six months long, and enrolled only people already drinking a fair amount. Even so, for regular drinkers with atrial fibrillation, cutting alcohol is one of the few things a randomised trial has shown to reduce recurrence.

Never skip or stop apixaban to drink

This is the most important sentence on the page.

The US label carries a boxed warning that premature discontinuation of any oral anticoagulant, including apixaban, increases the risk of thrombotic events. The UK label says lapses in therapy should be avoided.

This matters more with apixaban than it did with older anticoagulants. Warfarin’s effective half-life averages around forty hours; apixaban’s is roughly twelve. Protection falls away faster when doses are not taken, which is a pharmacological fact rather than a licence to plan around it.

Drinking and missed doses travel together. One adherence study found people who binge drank missed doses on 11.0% of drinking days against 2.4% of days among abstainers, with a clear same-day pattern. That research was not done in anticoagulated people and we found none that was. NICE separately lists adherence and alcohol among the things to consider when anticoagulation is reassessed. If a night out has been costing you doses, raise that with your prescriber. It is a solvable problem.

If you want to change anything about your anticoagulation, that decision belongs to the clinician who prescribed it. Not to this page. For anything about a missed dose, read the NHS apixaban page or ask your pharmacist today.

If the drinking is the part you cannot change

Being on an anticoagulant raises the stakes of heavy drinking, and that is a reason to get help rather than to feel worse.

If you drink heavily every day, do not simply stop on your own. Unmanaged alcohol withdrawal can be dangerous, and more complicated again when you are anticoagulated and may have liver involvement. That combination needs assessing by a clinician, not a plan made alone. What alcohol withdrawal actually involves and why detoxing at home carries risk are the useful starting points, along with the signs of dependence.

The Orchid Recovery is a residential addiction and mental health treatment centre in Hang Dong District, Chiang Mai, Thailand, for international English speaking adults, with a full-time on-site psychiatrist and an arrangement with a local hospital. Our pages on medically supervised alcohol detox and alcohol addiction treatment explain what that involves, our clinical team is listed here, and you can speak to us. Anyone on an anticoagulant needs a medical assessment before admission anywhere.

Sources

• NHS, Apixaban
• NHS, Atrial fibrillation
• electronic Medicines Compendium, Eliquis 5mg film-coated tablets, Summary of Product Characteristics
• DailyMed, ELIQUIS (apixaban) tablet, US prescribing information
• NICE, Atrial fibrillation: diagnosis and management (NG196)
• NICE, Venous thromboembolic diseases (NG158)
• NICE, Head injury: assessment and early management (NG232)
• NICE, Falls: assessment and prevention (NG249)
• Voskoboinik et al, Alcohol Abstinence in Drinkers with Atrial Fibrillation, N Engl J Med 2020
• Roth et al, Alcohol misuse, genetics, and major bleeding among warfarin therapy patients, Pharmacoepidemiol Drug Saf 2015
• Reddiess et al, Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation, CMAJ 2021
• Kelly et al, Alcohol consumption and the risk of major upper gastrointestinal bleeding, Am J Gastroenterol 1995
• Andersen et al, Alcohol consumption and the risk of a bleeding peptic ulcer, Epidemiology 2000
• Strate et al, Smoking, alcohol and risk of major gastrointestinal bleeding, PLoS One 2016
• Grewal et al, Intracranial haemorrhage after head injury among older patients on anticoagulation, CMAJ 2021
• Mukamal et al, Alcohol consumption and risk of falls in older adults, J Am Geriatr Soc 2004
• Braithwaite et al, A temporal and dose-response association between alcohol consumption and medication adherence, Alcohol Clin Exp Res 2005
• World Health Organization, Falls fact sheet
• NHS, Alcohol-related liver disease

Where this page stops

Nothing above is a reason to change how you take apixaban. That decision sits with the clinician who prescribed it.

The drinking is a separate question, and a treatable one. Our alcohol addiction treatment page and the residential programme it belongs to explain what that involves, and anyone on an anticoagulant is medically assessed before admission anywhere. If it would help to talk it through, our contact page is the way in.